Found "Early HTA": 401 results
The role of health technology assessment evidence in decision making: the case of Human Papillomavirus vaccination
Introduction: Cervical cancer is a major cause of deaths in female in low- and middle-income countries. The disease is preventable by introducing screening tests such as Pap smears, visual inspection with acetic acid (VIA) and HPV DNA testing. Recently, the first vaccine against human papillomavirus (HPV) was introduced to the health care market t
Unlocking the Potential of Public Health Decision Making in Africa: 6 Key takeaways from the Workshop
HITAP was invited to attend the “Strengthening Health and Disease Modelling for Public Health Decision Making” organised by the Bill and Melinda Gates Foundation (BMGF) and Wellcome on June 7–8, 2023 in Kigali, Rwanda. It brought together 110 virtual and on-site attendees, with 76 on-site modellers,
Early HTA: A Guide for Developing Pulmonary Tuberculosis Cost-Effective Tests Fitting the Healthcare Needs
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and represents a significant global health concern. Infectious agents can be easily spread through respiratory droplets, and TB patients face a significant risk of mortality.
The traditional sputum-based TB
India’s Chhattisgarh state; developing a plan for Universal Health Coverage
The Indian State of Chhattisgarh is drawing up its plans to extend universal health coverage (UHC) to its people. Discussions among public health experts, practitioners, and lawmakers, therefore, turn to planning the road ahead for this state and how it can deliver on its promise. With the state at
HTAsiaLink Annual Conference 2022: Abstracts and Pre-Conference Session Proposals Submissions are Now Closed!
Beyond expectations – More than 100 abstracts and almost 20 pre-conference session proposals are submitted and will be carefully reviewed by the Scientific Committee. Thank you for your interest and contribution to our network!Results of the review will be sent to the author/s by 30 September 2022 v
HTAsiaLink Annual Conference 2022: Abstracts and Pre-Conference Session Proposals Submissions are Now Closed!
Beyond expectations – More than 100 abstracts and almost 20 pre-conference session proposals are submitted and will be carefully reviewed by the Scientific Committee. Thank you for your interest and contribution to our network!Results of the review will be sent to the author/s by 30 September 2022 v
HTAsiaLink 2022: Result Announcement & Last Day for Early Bird Registration
Congratulations! – For those we are selected to present abstracts and pre-conference session proposal at the 10th HTAsiaLink Annual Conference which will be held at the Royal Cliff Grand Hotel, Pattaya, Thailand on 30 November to 2 December 2022. We appreciate All HTAsialink members who have joined
Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?
Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le
Wanrudee Isaranuwatchai, PhD
Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H
Topic prioritization and selection for health technology assessment 2009 (in Thai language)
The Health Intervention and Technology Assessment Program (HITAP ) has tried to develop mechanisms for HTA topic selection that are systematic, transparent and participatory. HITAP has organized a topic selection workshop annually in order to obtain HTA topics from stakeholders including decision makers, health professionals, academics, patient rep
10 / Page